Study of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Completed	`NCT01452022` - Performance of Inductigraft in Spinal Fusion	N/A
Withdrawn	`NCT02371122` - Spinal Cord Stimulation (SCS) Therapy Study	N/A
Not yet recruiting	`NCT01045473` - Prospective Study of Minimally Invasive Spine Surgery	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01452022 - Performance of Inductigraft in Spinal Fusion

N/A

Withdrawn

NCT02371122 - Spinal Cord Stimulation (SCS) Therapy Study

N/A

Not yet recruiting

NCT01045473 - Prospective Study of Minimally Invasive Spine Surgery

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01439464
Study type	Interventional
Source	BioAlpha Inc.
Contact	JunHyuk Seo, Ph.D.
Phone	82-31-746-5208
Email	seoscy@daewoong.co.kr
Status	Recruiting
Phase	N/A
Start date	October 2010
Completion date	June 2013

Study of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in Posterior Lumbar Interbody Fusion

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms